Review Article
The Human Frontal Lobes and Frontal Network Systems: An Evolutionary, Clinical, and Treatment Perspective
Table 17
Future treatment strategies proposed for the stroke model.
| (1) Small molecules (monoaminergic systems, antibodies against axonal growth inhibitor Nogo-A) | | (2) Growth factors (fibroblast growth factor, brain derived neurotrophic factor, hematopoietic growth factor, granulocyte colony stimulating factor) | | (3) Cell-based therapies (endothelial progenitor cells, intracerebral transplantation of cultured neuronal cells, intravenous mesenchymal stromal cells) | | (4) Electromagnetic stimulation | | (5) Device-based therapies | | (6) Task orientated and repetitive training-based interventions | |
|
|
Modified from [36].
|